Safety and Efficacy of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis
Clinical trial NCT03618784 · COMPLETED
Trial details
- NCT number
- NCT03618784
- Sponsor
- Kang Stem Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-11
- Primary completion
- 2021-10-05
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.